Signal Genetics IPO Research Information

Signal Genetics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Signal Genetics , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Signal Genetics	SGNL - NASDAQ	Priced at $10.00	$0.00	$0.00	850 K	6/18/2014
Underwriter(s): Aegis Capital Corp
Co-Manager(s):
Industry:
Filing(s): Filed 2014-03-19 Terms Added 2014-05-27 Terms Added 2014-06-02

About Signal Genetics (adapted from Signal Genetics prospectus):
They are an emerging commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer.

This description is adapted from Signal Genetics prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Signal Genetics "SGNL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.